Novo Nordisk and Amazon have signed a partnership agreement focused on AI-driven drug discovery and announced the launch of an innovation hub in London.
Summaries like this, in your inbox every morning.
Pick your industry and the AI tools you use, and get news related to your work every day.
Free · 30 seconds with Google · unsubscribe anytimeWhat is AIToday? →
Ask AI anything about this article. The AI reads this article, earlier AIToday articles, and Wikipedia, and cites its sources. Q&As are published on this page for other readers too.
CoreWeave fell 5% in premarket trading Friday and was on track to finish the week down 15%, after rebounding f…
In a Fortune commentary, Anthropic and General Catalyst argue markets price resilience's cost before its value
A longtime Anthropic investor told Fortune he expects shares priced around $1.8 trillion, below the company's…
In Q2, billionaires or their funds sold six 'Magnificent Seven' AI stocks
Nvidia was rising early Friday, even as the wider chip sector kept falling, Barron's reported
ElevenLabs completed a $300 million employee tender at a $22 billion valuation, and co-founder Mati Staniszews…
